Neuraxis Inc (NRXS)
AMEXHealth CareBiotechnologySnapshot 2026-09-04
$5.96-1.81%
Close 2026-09-04 · 1-day change
AMEXHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · NRXS
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenues | — | 3.6 | 2.7 | 2.5 | 2.7 | — |
| Total Revenues | — | 3.6 | 2.7 | 2.5 | 2.7 | — |
| Cost of Revenues | 0.8 | 0.6 | 0.4 | 0.3 | 0.3 | — |
| Gross Profit | 4.5 | 3.0 | 2.3 | 2.2 | 2.4 | — |
| Operating Expenses & Income | ||||||
| R&D Expenses | 0.6 | 0.5 | 0.2 | 0.2 | 0.2 | — |
| Operating Income | (7.7) | (7.8) | (7.2) | (6.7) | (3.4) | — |
| Earnings from Continuing Operations | ||||||
| Interest Expense | 0.1 | 0.1 | 0.2 | 0.5 | 0.3 | — |
| Net Income | ||||||
| Net Income | (7.7) | (7.8) | (8.2) | (14.6) | (4.8) | — |
| Per Share | ||||||
| Basic EPS | (0.63) | (0.95) | (1.22) | (4.50) | (2.77) | — |
| Diluted EPS | (0.63) | (0.95) | (1.22) | (4.50) | (2.77) | — |
| Basic Weighted Avg Shares | 12.1 | 9.1 | 6.9 | 3.3 | 2.0 | — |
| Diluted Weighted Avg Shares | 12.1 | 9.1 | 6.9 | 3.3 | 2.0 | — |
| Supplemental | ||||||
| EBITDA | — | (7.8) | (7.1) | (6.6) | (3.3) | — |
| EBIT | (7.7) | (7.8) | (7.2) | (6.7) | (3.4) | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.